Medicine and Dentistry
Malignant Neoplasm
100%
Medicare
98%
Breast Cancer
71%
Health Care Cost
62%
Surgery
62%
Logistic Regression Analysis
52%
Neuroendocrine Tumor
51%
Overall Survival
50%
Elderly Patient
40%
Multiple Chronic Conditions
36%
Odds Ratio
32%
Diseases
29%
Surveillance, Epidemiology, and End Results
29%
Colorectal Carcinoma
24%
Systematic Review
23%
Alzheimer's Disease
21%
Neoplasm
21%
Prostate Cancer
20%
Diabetes
20%
Recurrent Disease
20%
Carcinoid Syndrome
18%
Health Care
18%
Radiation Therapy
17%
Primary Tumor
17%
Pancreas Cancer
17%
Bariatric Surgery
16%
Cohort Analysis
14%
Lymph Node
14%
Systemic Therapy
13%
Proportional Hazards Model
13%
Melanoma Skin Cancer
12%
Chi Square Test
12%
Hazard Ratio
12%
Race Difference
12%
Abdominal Cancer
11%
Neuroendocrine Carcinoma
11%
Survival Analysis
11%
Adjuvant Chemotherapy
11%
Cross Sectional Study
11%
Lung Cancer
11%
Octreotide
10%
Cost-Effectiveness Analysis
10%
Gastrectomy
10%
Da Vinci Surgical System
10%
Immune Checkpoint Inhibitor
10%
BRCA1
10%
Women Veterans
10%
Chronic Myelogenous Leukemia
10%
Free Tissue Graft
10%
Keyphrases
United States
91%
Older Adults
49%
Neuroendocrine Tumor
46%
Medicare Beneficiaries
40%
Healthcare Expenditure
39%
Overall Survival
36%
Comorbidity
35%
Elderly Patients
33%
Surveillance Epidemiology
33%
Surgical Resection
29%
Melanoma
29%
Chronic Obstructive Pulmonary Disease
28%
National Cancer Database
26%
Chronic Physical Illness
25%
Opioids
23%
Confidence Interval
23%
Survival Outcomes
22%
Related Dementia
21%
Alzheimer's Dementia
21%
Population-based Study
21%
Chemotherapy
20%
Odds Ratio
19%
Diabetes
19%
Survival Benefit
19%
Treatment Patterns
19%
Medicare
19%
Multivariable Logistic Regression
18%
Adjusted Odds Ratio
18%
Medicaid Patients
18%
Pancreatic Cancer
18%
Risk Factors
17%
Locoregional
17%
Surgical Treatment
17%
Depression Treatment
17%
Chi-square Test
17%
Hypertension
16%
Oral Anticancer Drugs
16%
Mutation Testing
16%
Women Veterans
16%
Racial Differences
16%
Bariatric Surgery
16%
COVID-19 Related
16%
Colorectal Cancer
16%
Metastatic Colorectal Cancer (mCRC)
15%
Hazard Ratio
15%
Older Patients
15%
Newly Diagnosed
14%
Epidermal Growth Factor Receptor
14%
Systemic Therapy
14%
Logistic Regression
14%